NeoClarityne™ Tablets


Tablet Blister Packs 10 30
scheduling status
S2
registration number
35/5.7.1/0208
What NeoClarityne™ Tablets is and what it is used for
NeoClarityne Tablets are indicated for the relief of symptoms associated with allergic rhinitis. NeoClarityne Tablets are also indicated for the short-term relief of symptoms associated with chronic idiopathic urticaria.
dosage
Adults and adolescents (≥ 12 years of age): One tablet once a day regardless of mealtime for the relief of symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and chronic idiopathic urticaria. Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient’s disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance. In persistent allergic rhinitis (presence of symptoms for more than 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during allergen exposure periods). Improvement of symptoms associated with seasonal allergic rhinitis usually becomes noticeable within 1 -2 hours after administration of desloratadine.
how to take
For oral use only.
What NeoClarityne™ Tablets contains
5.0 mg desloratadine.
other ingredients
Calcium phosphate, maize starch, microcrystalline cellulose, purified water and talc. Contains sugar as Lactose monohydrate.
Therapeutic classification
Antihistaminics.
© 2026 SAHPRA. ALL RIGHTS RESERVED